Norethindrone
Norethindrone
Definition
A synthetic progestational substance with some anabolic, estrogenic, and androgenic properties. Norethindrone binds to the progesterone intracellular receptors in the reproductive system and the resultant activated complex interacts with specific DNA sites. This leads to an alteration in protein synthesis and results in an inhibition of LH release. Consequently, it inhibits ovulation and changes the normal cycle of cervical mucus and endometrium.
Also known as Camila, Errin, Micronor, NORETHINDRONE, Norethisterone, Norlutin — per NCIT
Also identified as
- ATC G03AC01 per RXNORM
- ATC G03DC02 per RXNORM
- NCIT NCIT:C62059 per NCIT
- SCTID 126102009 per RXNORM
- SCTID 63758001 per RXNORM
- UNII T18F433X4S per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Osteoporosis | may prevent | MEDRT · Public domain (U.S. Government work) |
| Endometriosis | may treat | MEDRT · Public domain (U.S. Government work) |
| Hypogonadism | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Female reproductive system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Genitourinary system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Gonad | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Reproductive system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
4 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.